النص 🔗
WEBVTT
00:00:01.919 --> 00:00:08.800
I can remember in November 2019, I was chatting to a guy called Mark Wildgust, who's a pretty senior guy at Jansen, the super, super, super person.
00:00:08.960 --> 00:00:15.279
And we were talking about how one implemented some of the novel therapies in prostate cancer and what was the comparator.
00:00:15.359 --> 00:00:17.039
And I said, Well, I was talking about chemotherapy.
00:00:17.199 --> 00:00:19.199
He sort of said, Simon, no one gets chemotherapy.
00:00:19.280 --> 00:00:20.879
And I was like, No, they do, Mark, they do.
00:00:20.960 --> 00:00:22.320
We did these studies, they showed whatever.
00:00:22.399 --> 00:00:23.600
And he was like, no one gets chother.
00:00:23.679 --> 00:00:27.039
And he then he showed me some market research, and no one got chemotherapy.
00:00:27.120 --> 00:00:29.679
And I audited my own practice and it was very low.
00:00:29.920 --> 00:00:31.600
It was a real eureka moment for me.
00:00:31.679 --> 00:00:39.200
It was a moment where I realized that just because something's published in the New England Journal of Medicine doesn't mean it's going to make it into the clinic, even my own clinics.
00:00:39.280 --> 00:00:42.719
And then I said to people in my academic group, how many patients then get chemotherapy?
00:00:42.880 --> 00:00:44.240
And everyone said 70-80%.
00:01:40.879 --> 00:01:45.359
On today's episode of Pharma Sessions, I am thrilled to welcome Dr.
00:01:45.439 --> 00:01:52.400
Simon Chowdhury, a medical oncologist and a leader in urological to cancer care, clinical research, and medical education.
00:01:52.640 --> 00:01:52.879
Dr.
00:01:53.040 --> 00:02:01.760
Chowdhury has spent his career at the intersection of the frontline oncology practice, clinical trials, translating complex science into better patient care.
00:02:01.920 --> 00:02:08.400
And what makes his perspective really compelling is his focus on a challenge that is affecting nearly every part of medicine today.
00:02:08.639 --> 00:02:13.199
How do we get the right knowledge to the right clinicians and patients in a form they can actually use?
00:02:13.439 --> 00:02:30.560
So we're going to talk a bit today about a project that Simon's working on that's really, really interesting called Open Medicine, which is attempting to bridge the gap between academic expertise, real world care, and provide trusted doctor-led education, really in a world that's absolutely flooded with misinformation.
00:02:30.719 --> 00:02:32.479
So misinformation, I should say.
00:02:32.639 --> 00:02:34.159
So I'm pretty excited about this.
00:02:34.240 --> 00:02:36.400
It's a topic that I have a lot of personal interest in.
00:02:36.560 --> 00:02:38.080
I think it'll be a great conversation.
00:02:38.319 --> 00:02:40.800
Simon, did I do an okay job introducing you?
00:02:41.280 --> 00:02:43.599
You were far too kind, Jonathan, far too kind.
00:02:43.840 --> 00:02:44.719
But thank you very much.
00:02:44.879 --> 00:02:53.919
And
Load full transcript
uh I'm really excited to be here and really excited to chat to you about the new project and how that may well fit in and hopefully help shape medical education and improve the sheet.
00:02:54.159 --> 00:02:54.319
All right.
00:02:54.400 --> 00:02:58.400
So before we get into all of that, I always like to do a quick get to know people.
00:02:58.479 --> 00:03:08.960
And lately I've been on this kick of uh asking as an icebreaker, what is your go-to or go-to's for karaoke when you're forced to perform?
00:03:09.120 --> 00:03:10.319
Or maybe choose to perform.
00:03:10.800 --> 00:03:11.439
You come to London.
00:03:11.759 --> 00:03:13.599
I think Jonathan's actually a very talented musician.
00:03:13.680 --> 00:03:15.120
There's a guitar in the background.
00:03:15.280 --> 00:03:27.840
I'm a very enthusiastic uh mute karaoke singer, and I was once told when I was singing very much out of key that I should sing Daydream Believer by the monkeys because they were a manufactured band and it's got a very narrow vocal range.
00:03:27.919 --> 00:03:29.439
So probably that's one of my songs.
00:03:29.599 --> 00:03:35.759
And then my goddaughter Adele got me to learn the lyrics to super bass by Nicki Minaj, which is super difficult to learn.
00:03:36.080 --> 00:03:43.120
Took me four months of walking around London medical conferences doing this wonderful boys and boom system, top-down AC with the cooling system, etc.
00:03:43.360 --> 00:03:43.599
etc.
00:03:43.919 --> 00:03:46.400
So those are the ones we'll do, Jonathan, when we love it.
00:03:46.639 --> 00:03:48.719
Unfortunately, I have a lot of enthusiasm for singing.
00:03:48.879 --> 00:03:59.520
I can play the guitar okay, but I know I'm not tone-deaf because I can hear my own singing and I can hear what it sounds like, but that is just a skill that uh unfortunately passed me by.
00:03:59.759 --> 00:04:06.400
But I will say that doesn't prevent me from trying to do a Chris Cornell impersonation at at any given moment in time.
00:04:07.439 --> 00:04:10.400
So, all right, let's start by looking back a bit.
00:04:10.479 --> 00:04:14.639
Why don't you I know you've done a lot in oncology and research and medical education?
00:04:15.039 --> 00:04:21.920
Maybe take us through a little bit of your career, but one thing that's always interesting is the motivation, right?
00:04:22.000 --> 00:04:26.160
What first drew you to this work and and what's kept you committed to it?
00:04:26.560 --> 00:04:30.480
I think I was thinking about this, and what drew me to the work was the patients.
00:04:30.720 --> 00:04:36.800
So, age five, my dad wanted to be the doctor who wanted me to go to Cambridge University and be a doctor at Guy's Hospital.
00:04:36.879 --> 00:04:38.480
And and that's what I ended up doing.
00:04:38.720 --> 00:04:39.839
Which one of us more mad?
00:04:40.000 --> 00:04:40.639
Probably me.
00:04:40.800 --> 00:04:44.959
And as a very wet, behind the ears 24-year-old, I ended up on the wards at Guys and
St.
00:04:45.120 --> 00:04:46.160
Thomas' Hospital.
00:04:46.319 --> 00:04:49.439
And the thing that I noticed was how amazing the patients were.
00:04:49.600 --> 00:04:51.360
You just saw the best of human nature.
00:04:51.439 --> 00:04:58.560
So I would be coming in on a Monday morning, often having maybe done some karaoke at the weekend, and the patients were like, Oh, it's lovely to see you, Dr.
00:04:58.639 --> 00:04:59.040
Cherry.
00:04:59.279 --> 00:04:59.839
How's your mum?
00:04:59.920 --> 00:05:00.480
How's your dad?
00:05:00.639 --> 00:05:02.079
How did Manchester United do?
00:05:02.160 --> 00:05:04.079
Or the Boston Celtics, maybe.
00:05:04.240 --> 00:05:08.000
And I was just amazed at that the you saw the best of human nature.
00:05:08.079 --> 00:05:12.399
So it really motivated me to work hard to try and help those people.
00:05:12.560 --> 00:05:21.279
And I think probably my parents came from very, very simple backgrounds, and they worked very hard, they were very determined, they were smart people, very kind people.
00:05:21.600 --> 00:05:25.120
And I think they gave me a real I had opportunities that they never had.
00:05:25.199 --> 00:05:28.720
And so I wanted to do something in an area where there was clearly need.
00:05:28.879 --> 00:05:33.839
And oncology has was the intersection of need and also just amazing patients.
00:05:33.920 --> 00:05:37.920
You just see the best of human nature, and you still do, and you see such fortitude.
00:05:38.000 --> 00:05:40.399
You see the best of human nature, the best of human spirit.
00:05:40.560 --> 00:05:49.279
So helping cancer patients is just a passion for me, and it's hard because a lot of cancer patients still don't do well, but they're amazing people.
00:05:49.519 --> 00:05:51.920
I'm very, very privileged to have many of them in my life.
00:05:52.000 --> 00:05:53.600
So yeah, that's absolutely incredible.
00:05:53.680 --> 00:06:02.720
I mean, you're talking about seeing people going through what is oftentimes probably the hardest thing that they or they families will have to personally deal with.
00:06:02.879 --> 00:06:08.399
So there must be how do you I guess it's a question, just a personal question for me, but you've been doing this for quite some time.
00:06:08.639 --> 00:06:11.360
How do you deal with that emotionally, right?
00:06:11.439 --> 00:06:14.319
So that you're able to provide that support and be vested.
00:06:14.480 --> 00:06:17.680
But as you say, some of these prognoses are really pretty grim.
00:06:17.920 --> 00:06:20.000
I think I'm probably the worst person to say how to deal with it.
00:06:20.079 --> 00:06:23.040
I'd probably deal with it a karaoke barn with I think great friends.
00:06:23.120 --> 00:06:24.480
I've got incredible friends.
00:06:24.639 --> 00:06:26.560
And I think now I recognize it a lot more.
00:06:26.639 --> 00:06:31.759
So one of the reasons why I've stepped away to a degree from clinical medicine is got too much for me, to be honest.
00:06:32.000 --> 00:06:35.680
Got to a point where I was just too emotionally engaged.
00:06:35.759 --> 00:06:41.839
Um, one of my bosses, who's sadly no longer with us, a guy called Martin Gore from the Boar Marsden, he said to me, You really care, don't you?
00:06:41.920 --> 00:06:42.959
And I said, Doesn't everyone?
00:06:43.040 --> 00:06:44.720
He said, No, not everyone does, Simon.
00:06:44.800 --> 00:06:47.279
And he said, You like me will run into compassion fatigue.
00:06:47.360 --> 00:06:48.160
And I think I did.
00:06:48.399 --> 00:06:54.480
And I think now with open medicine and just doing a little bit of clinical medicine, I've got a much better balance.
00:06:54.639 --> 00:06:57.519
I think the volume of patients I was seeing before was just too much.
00:06:57.759 --> 00:07:00.560
I look at a lot of my friends, colleagues, in awe of them.
00:07:00.639 --> 00:07:12.560
And I think one of the things that we're trying to do is to make life easier for doctors and patients, just so that the increasing complexity of science, medicine, therapies, it's really hard to stay on top of that.
00:07:12.639 --> 00:07:14.480
And I think people are burnt out.
00:07:14.639 --> 00:07:24.480
So I think if we can simplify things and make life a bit easier for everyone, that's so before we get into open medicine and what you're working on now.
00:07:24.560 --> 00:07:31.120
Uh when you transitioned away from clinical practice or or somewhat, what are you transitioning into?
00:07:31.279 --> 00:07:32.879
What were you working on prior to this?
00:07:33.199 --> 00:07:37.040
So I was working very much in an academic clinical centre.
00:07:37.199 --> 00:07:40.720
I was the head of the GU uh department there, which was great.
00:07:40.959 --> 00:07:43.519
In South London, which I love London.
00:07:43.600 --> 00:07:46.160
It's a brilliant city, it's got a great vibrancy.
00:07:46.240 --> 00:07:49.360
It's also got a huge amount of poverty immigrants.
00:07:49.519 --> 00:07:52.000
My dad was an immigrant to this country to the UK.
00:07:52.160 --> 00:07:53.600
So I actually really like the mix.
00:07:53.680 --> 00:07:55.040
I love the diversity of London.
00:07:55.279 --> 00:07:58.079
There's complex type of diversity for both of our countries.
00:07:58.319 --> 00:08:09.519
But for me, looking after people from India, Australia, the West Indies, Europe, as well as the indigenous South London population, there's a real authenticity there.
00:08:09.680 --> 00:08:15.040
I'm always sort of saying to people, I don't particularly want to look after people who don't have real problems.
00:08:15.120 --> 00:08:18.560
Now I now see that anyone coming to a doctor probably does have a real problem.
00:08:18.720 --> 00:08:27.439
But I think back in the 90s, I was probably a little bit dismissive of some of the more softer problems and some of some things around mental illness, such as I'd be much more attuned to now.
00:08:27.600 --> 00:08:36.559
But I think there's an
authenticity in that population, and there's an authenticity in oncology that I think is just it really, it really speaks to me.
00:08:36.799 --> 00:08:43.759
So in the unit there, we built it from quite a small unit up into one of the world leading units, a lot of research.
00:08:43.919 --> 00:08:49.840
And then I realized that actually to get the research out there, we needed to get the education, and that became a passion for me.
00:08:50.080 --> 00:08:51.919
Working a lot with with pharma.
00:08:52.000 --> 00:08:55.840
I think there's a lot of some people are very dismissive of pharma, but I'm certainly not.
00:08:56.000 --> 00:09:03.519
It's very easy for doctors to make out that we're the that we're the uh we're the angels and they're the devils, whatever, the good guys, the bad guys and girls.
00:09:03.679 --> 00:09:04.720
It's definitely not like that.
00:09:04.799 --> 00:09:05.759
We're all on the same team.
00:09:05.840 --> 00:09:07.200
We we all want the same thing.
00:09:07.360 --> 00:09:12.320
And I've been so impressed with my pharma colleagues and friends who have a real passion to to improve things.
00:09:12.480 --> 00:09:27.919
So I think we all need to work together and just do what we can to get the right therapies to the right people and make the that's been my experience working with pharma too, you know, particularly in medical affairs, is where I've spent a good deal of time.
00:09:28.000 --> 00:09:32.240
And those people are really just get the right patient to the right drug at the right time.
00:09:32.320 --> 00:09:41.840
But even, I mean, if we if we're being honest about it, there's a real need for commercial to move faster because at the end of the day, a medicine sitting in a lab doesn't help anybody, right?
00:09:41.919 --> 00:09:49.600
It needs to get into patients' bodies, and that means there's a lot of stuff that has to happen and it needs to get regulatory approval and all of that.
00:09:49.759 --> 00:09:52.720
So I think that it's it needs to be give and pull.
00:09:52.799 --> 00:09:54.000
This is or give and take.
00:09:54.080 --> 00:09:55.840
This is my personal 100%.
00:09:56.480 --> 00:10:00.639
To be honest, without the commercial world, we wouldn't have the finances to develop these drugs.
00:10:00.720 --> 00:10:07.840
So I think we need to probably reassess some aspects of it, but I think far too many doctors are dismissive of that side of it.
00:10:07.919 --> 00:10:17.759
It's a commercial world, and actually, part of our role is to help get those therapies out there because the successful therapies will pay for the trials that lead to other therapies coming through.
00:10:17.919 --> 00:10:19.120
Uh, I strongly believe that.
00:10:19.200 --> 00:10:24.159
And, you know, as I say, I work a lot with people in pharma and they're often the smartest and most decent people.
00:10:24.240 --> 00:10:28.399
And then you have to look at the vaccine programs that happened, you know, that wasn't that long ago, you know.
00:10:28.480 --> 00:10:29.919
I suppose it's five years ago now.
00:10:30.080 --> 00:10:35.519
But the the pharma companies did such a brilliant job getting the giving the vaccines out there and doing along those lines.
00:10:35.679 --> 00:10:38.879
I love bringing patients along to meet colleagues in pharma.
00:10:38.960 --> 00:10:43.840
And the first thing the patients say is they say, Cyber Science should be thanking you because you're the real reason I'm alive.
00:10:43.919 --> 00:10:44.720
And it's true.
00:10:44.799 --> 00:10:49.360
I'm not the person making, you know, the clever therapies in prostate or kidney or bladder cancer.
00:10:49.440 --> 00:10:52.399
It's the guys and it's guys and girls in the in the pharma industry.
00:10:52.559 --> 00:10:53.919
So, you know, I think they need to be thought of it.
00:10:54.080 --> 00:10:54.480
Well, that's great.
00:10:54.559 --> 00:10:57.679
And I feel like that is a whole conversation can be had about that.
00:10:57.759 --> 00:11:02.720
But I'm actually really interested in this knowledge gap, right?
00:11:02.799 --> 00:11:13.519
Because even as you are describing the patient populations that you're treating in South London, uh I would assume it's not just that there's an information gap.
00:11:13.600 --> 00:11:26.720
There's probably many different information gaps depending on who is in your audience and and what types of content they're they have accessible or that they're consuming, or be uh at some point in times being served up to them by the algorithms.
00:11:26.960 --> 00:11:33.759
So when did you first start to realize there was a big gap between cutting edge knowledge and what actually reaches patients?
00:11:50.230 --> 00:11:59.269
I think it was slowly coming to me because I've got a lot of friends who work in the community and I realized that they were that they just didn't have the privilege that I had.
00:11:59.350 --> 00:12:08.870
They were seeing far many, many more patients without the infrastructure, nursing, pharmacy, doctors, community with regards to that, the community, academic community there.
00:12:09.110 --> 00:12:11.509
I was very fortunate I could go to all the meetings.
00:12:11.750 --> 00:12:16.070
I was invited to do these things, and a lot of stuff was pitched towards me.
00:12:16.230 --> 00:12:25.029
If there was one moment in time, I can remember in November 2019, I was chatting to a guy called Mark Wildgust, who's a pretty senior guy at Jansen, a super, super, super person.
00:12:25.269 --> 00:12:31.669
And we were talking about how one implemented some of the novel therapies in prostate cancer and what was the comparator.
00:12:31.750 --> 00:12:35.750
And I said, Well, I was talking about chemotherapy, and he sort of said, Simon, no one gets chemotherapy.
00:12:35.830 --> 00:12:37.509
And I said, No, they do, Mark, they do.
00:12:37.590 --> 00:12:44.149
We did these studies, they showed whatever, and he was like, No one gets and then he showed me some
market research and no one got chemotherapy.
00:12:44.230 --> 00:12:46.789
And I audited my own practice and it was very low.
00:12:47.029 --> 00:12:48.629
It was a real Eureka moment for me.
00:12:48.710 --> 00:12:56.629
It was a moment where I realized that just because something's published in the New England Journal of Medicine doesn't mean it's going to make it into the clinic, even my own clinics.
00:12:56.789 --> 00:13:01.269
And then I said to people in my academic group, well, how much patient how many patients do you think get chemotherapy?
00:13:01.430 --> 00:13:02.789
And everyone said 70, 80%.
00:13:03.350 --> 00:13:05.669
And then we did a UK audit and it was 27%.
00:13:06.070 --> 00:13:07.110
It's a bit lower in the U.
00:13:07.190 --> 00:13:12.870
But the UK is fortunate and unfortunate in our national healthcare system, which I'm very proud of, but it's very joined up.
00:13:12.950 --> 00:13:17.350
But it means that implementation of therapies is much more straightforward than, say, in the US.
00:13:17.430 --> 00:13:18.870
And I go, I'm a big fan of the US.
00:13:19.029 --> 00:13:23.110
I trained at Dona Farbo, have lots of friends there, my cousin's still there.
00:13:23.269 --> 00:13:26.310
I'm not one of these Brits who thinks the US is awful, far from.
00:13:26.470 --> 00:13:30.389
I think we're actually, our healthcare systems could work much more closely together.
00:13:30.470 --> 00:13:39.029
But I think it's harder to it's harder to initiate and popularise and democratise the therapy in the US because it's a bit more broken down, I think, than the UK.
00:13:39.190 --> 00:13:41.430
But in the UK, the uptake was low.
00:13:41.590 --> 00:13:48.629
And so it made me really stop, pause, and focus some energies on how one changes that and how one.
00:13:48.710 --> 00:13:51.190
And it made me think most people are treated in the community.
00:13:51.350 --> 00:13:58.870
They're not treated in academic centres like my own or Barber, they're treated out in the community in the UK, the US, Germany, France, etc.
00:13:59.190 --> 00:14:01.430
Most countries, if not all countries, is like that.
00:14:01.590 --> 00:14:04.710
And I think, and patients want to be treated in the community.
00:14:04.789 --> 00:14:18.629
They don't want them, they don't want to come into travel three hours to come into a hot, dirty, sticky London, or traveling to Boston or New York or to Hamburg or Paris, just because those cities, you know, they want to stay close to home.
00:14:18.789 --> 00:14:25.430
Most of our patients are older, they trust the local doctors quite rightly who have looked after them for a long period of time.
00:14:25.590 --> 00:14:29.190
And we need to work with those doctors to make life a bit easier.
00:14:29.430 --> 00:14:30.230
If that makes a ton of sense.
00:14:30.310 --> 00:14:35.990
I mean, that even mirrors in the US my own experience of I live uh a couple hours south of Philadelphia.
00:14:36.149 --> 00:14:41.990
And when people have serious things going on, they go north uh to Philly, right?
00:14:42.149 --> 00:14:46.629
They're going to Penn, they're going to CHOP, they're going to those real centers of excellence.
00:14:46.870 --> 00:14:58.470
This need that you've identified, right, to democratize or to essentially spread evidence-based clinical care from academic settings out to the broader clinical world.
00:14:58.710 --> 00:15:05.110
Tell me a bit about open medicine and motivation and kind of what made you go from that eureka moment to where we are now.
00:15:05.430 --> 00:15:21.430
So I've been working a little bit in medical education, some of it with pharmaceuticals, some of it independently, trying to understand, trying to sort of read myself around about innovation, adoption, looking at things like tech, music, electronics, how they'd done things where people adopt a lot quicker than medicine.
00:15:21.590 --> 00:15:22.950
Medicine's very conservative.
00:15:23.029 --> 00:15:28.549
And I think the maxim of do no harm is something that we probably hide behind a little bit.
00:15:28.629 --> 00:15:30.629
And oncologists are not the best at this.
00:15:30.870 --> 00:15:36.310
The surgeons are and the hematologists are much better than the medical oncologists.
00:15:36.470 --> 00:15:41.509
So if you look at the implementation of robotic prostatectomy, that was incredible.
00:15:41.669 --> 00:15:45.509
And I think our surgical colleagues have to be thanked to a degree with that.
00:15:45.669 --> 00:15:46.789
The evidence base is low.
00:15:46.870 --> 00:15:50.629
There's no randomized trial showing that robotic surgery is better than open surgery.
00:15:50.870 --> 00:15:56.470
But I think they showed that with an energy and an education program, they were able to do that.
00:15:56.549 --> 00:15:59.350
And that's a tech which is different giving therapies.
00:15:59.590 --> 00:16:10.629
Open medicine came about from a passion project, really, for myself and one of my fellow founders of Eat Ghost, who's a super, super is our CEO, super intelligent guy, very, very thoughtful.
00:16:10.870 --> 00:16:12.310
We sort of the yin and the yang.
00:16:12.389 --> 00:16:15.830
I do a lot of uh, I speak a lot, he thinks a lot.
00:16:15.990 --> 00:16:18.549
So we're a good uh we're a good couple where that's concerned.
00:16:18.710 --> 00:16:28.629
But both of us are passionate about education, and we both wanted something that is going to it's a commercial operation, but we also wanted something that's going to benefit beyond that.
00:16:28.710 --> 00:16:37.430
And we wanted a platform that is completely open, is free at point of access, doesn't have adverts, doesn't have undue bias from anyone.
00:16:37.669 --> 00:16:40.470
Farmers, the obvious people, but as I said, they're not the enemy.
00:16:40.629 --> 00:16:44.149
And we wanted to get what's essentially what's in experts' minds.
00:16:44.230 --> 00:16:54.470
So let's take an expert at Memorial Sloan Care Strong,
take what's in that expert's mind and cascade it into a way that is easily accessible on a mobile phone.
00:16:54.549 --> 00:17:00.389
So that someone in the community or a trainee, that UX experience, they can join the conversations.
00:17:00.789 --> 00:17:05.269
The one who runs mobile should know they're made possible by the team and see what we're doing.
00:17:05.669 --> 00:17:10.789
Excent complex stuff into clear, actionable insight.
00:17:11.109 --> 00:17:21.910
For years, Xcent has made complicated data sets simple to help commercial, medical, and operations teams map what's happening, predict what's next, and make stronger decisions faster.
00:17:22.150 --> 00:17:25.829
And now there's an added AI layer that makes everything work so much better.
00:17:26.069 --> 00:17:33.029
I was actually pretty jaded about some of the AI approaches I'd seen, but when XSunt showed me theirs, I actually left my job to come work for them.
00:17:33.190 --> 00:17:33.990
It's really awesome.
00:17:34.150 --> 00:17:41.109
So if you want to understand your market, your customers, or your performance with more clarity than ever, check out xunt.com.
00:17:41.269 --> 00:17:44.549
That's xs-unt.com.
00:17:44.870 --> 00:17:47.589
Alright, let's jump back into the episode.
00:17:58.630 --> 00:18:11.190
It makes a tremendous amount of sense, and I love the idea of pulling parallels from the tech world, pulling parallels from other industries, because at the end of the day, sometimes people, as they're designing these programs, forget that doctors are fundamentally people, right?
00:18:11.430 --> 00:18:18.710
And if it is if they can see something in 15 seconds versus 15 minutes, there's a massive benefit to that.
00:18:19.109 --> 00:18:38.870
Is your take that this simplification of taking the Uber expert in a field and putting their evidence-based guidelines essentially into this format is solving the access problem via faster access, more complete access?
00:18:38.950 --> 00:18:41.029
Like what is what is the ultimate goal here?
00:18:41.349 --> 00:18:47.430
I think the ultimate goal is really to share knowledge in a way that is truly democratic.
00:18:47.670 --> 00:18:51.349
I think at the moment we have, I'm an academic or a pseudo-academic.
00:18:51.430 --> 00:18:52.789
I don't really think of myself as an academic.
00:18:52.870 --> 00:18:56.230
I like to think of myself as a pragmatic, but I work in academic centers.
00:18:56.390 --> 00:18:59.670
I'm, you know, have a role at the Medical Research Council in the UK.
00:18:59.829 --> 00:19:05.750
You know, I go and chat to people at Dana Farber, my cousin's the head of radiation biology there, very smart guy.
00:19:05.910 --> 00:19:07.990
So I mix with the great and the good.
00:19:08.150 --> 00:19:12.950
And I think the problem is that often we talk about stuff that is really fine detail.
00:19:13.109 --> 00:19:24.870
And sometimes, not really amongst my friends so much, but sometimes you see people showing off
academically, making it more complicated, showing that they understand the genomic side of things and not making it more accessible.
00:19:24.950 --> 00:19:26.710
So for me, I want to strip it back.
00:19:26.950 --> 00:19:35.349
I really like the concept of simple Simon, of sort of saying, sort of saying to someone, if you understand something really well, explain it in a really simple way.
00:19:35.589 --> 00:19:38.789
When we go to the baseball, Jonathan, I don't understand baseball so well.
00:19:38.870 --> 00:19:39.829
And you'll strip it back.
00:19:39.910 --> 00:19:41.029
You are a very good communicator.
00:19:41.109 --> 00:19:42.710
You'll make it fun and easy.
00:19:42.870 --> 00:19:43.670
That's what we want to do.
00:19:43.750 --> 00:19:47.430
We want to make it fun and easy so that people actually enjoy it.
00:19:47.589 --> 00:19:53.190
I get a lot of my education from X, which surprises people more than more than journals, more than academic meetings.
00:19:53.349 --> 00:19:55.269
I get it on X and I interact that way.
00:19:55.349 --> 00:19:56.789
And that's easy for me as a man.
00:19:56.950 --> 00:20:00.549
I think it's much harder for women on X and much harder for people with more diversity.
00:20:00.630 --> 00:20:06.710
So we wanted a platform where it's open for everyone, but the content is verified.
00:20:06.870 --> 00:20:11.990
And also it's a safe place where people are abused, and we're gonna have very strict regulation there.
00:20:12.150 --> 00:20:13.670
Not regulation, we want debate.
00:20:13.750 --> 00:20:21.190
We want people to say I do it this way, or this is why I do it this way, but respectful, collegiate debate, not sort of calling people names and stuff.
00:20:21.269 --> 00:20:29.509
And I've seen a lot of my female friends come off X, and I feel very sad because A, they added a huge amount, and they're some of the smartest people I know.
00:20:29.750 --> 00:20:31.750
We want somewhere where they can go and feel safe.
00:20:32.069 --> 00:20:32.470
It's great.
00:20:32.789 --> 00:20:42.309
And especially if you're trying to do this from a professional setting where you're hoping to further patient care, the last thing you want is heaps of abuse coming at you.
00:20:42.470 --> 00:20:47.269
So I at one point in my career I'd I had worked for this company in the US, it was called Cermo.
00:20:47.430 --> 00:21:00.230
And what we had was a network of physicians, and we had a pretty decent size chunk, at least at the time, of the US practicing physicians.
00:21:00.470 --> 00:21:09.269
And we were seeing some of this happening, and what what we ultimately found was that it did, it wasn't necessarily a censorship.
00:21:09.349 --> 00:21:14.309
Like I can't actually even remember a time where we had to tell people to rein it in.
00:21:14.549 --> 00:21:31.190
It was more about creating an environment where there were places to talk about clinical issues, there were places to talk about the business of running a small practice, essentially a small business in the US and dealing with insurance agencies and all of the like.
00:21:31.349 --> 00:21:33.109
So I've spent some time on open medicine.
00:21:33.269 --> 00:21:35.829
What I had seen was really flow charts, right?
00:21:35.910 --> 00:21:37.910
And this graphical simplified interface.
00:21:37.990 --> 00:21:44.870
I'd encourage people that are interested to check it out as a way to see how science can be communicated.
00:21:45.190 --> 00:21:53.430
Is your vision that this becomes a community environment for having back and forth discussions around the recommended treatment protocols?
00:21:53.750 --> 00:21:58.789
I think ultimately what we've got at the moment, and you described it really well, is what we call living algorithms.
00:21:58.950 --> 00:22:06.470
So we found from our research that actually what people wanted was these flowcharts that would guide them through a clinical problem.
00:22:06.630 --> 00:22:11.750
So let's say something in my area, say advanced castrate sensitive prostate cancer.
00:22:11.910 --> 00:22:15.750
How does how does say Nearaj Agual, one of the world's leaders, address that?
00:22:16.150 --> 00:22:18.150
And Niraj is one of our thought leaders.
00:22:18.309 --> 00:22:22.150
He helped us to design an algorithm, and it's a click-through thing.
00:22:22.309 --> 00:22:27.109
What we noticed was these algorithms that were kind of like PowerPoint slides hadn't changed in the last 30 years.
00:22:27.190 --> 00:22:35.349
And I think that horrified my fellow founders who are brilliant at software, at website design, at AI, about search engine engine optimization.
00:22:35.509 --> 00:22:37.029
And I'm learning so much from them.
00:22:37.190 --> 00:22:39.430
The other founders are not doctors, thank goodness.
00:22:39.670 --> 00:22:51.589
So we wanted to build something that's interactive, has really great user experience, but takes the best expertise in a disease area, but puts it in a format that is user-friendly.
00:22:51.750 --> 00:22:57.670
And I think what we have at the moment is we're full of a world of PDFs, we're full of a world of that's text heavy.
00:22:57.829 --> 00:23:03.990
And I think as you will know, and as I will know from the younger people I work with, that isn't their world anymore.
00:23:04.150 --> 00:23:07.910
They've grown up on X, Instagram, Facebook, whatever.
00:23:07.990 --> 00:23:09.190
They want rolling content.
00:23:09.349 --> 00:23:16.789
They want content that is much more visual friendly and much more, much less more consumable, right?
00:23:16.950 --> 00:23:17.829
More yes.
00:23:18.150 --> 00:23:19.910
Well, sort of depth is more interactive.
00:23:20.069 --> 00:23:24.950
I think I now look at it, I read quite a lot of papers and things because I'm still interested, I still write them.
00:23:25.029 --> 00:23:32.150
But I sometimes, yeah, my heart sinks when someone sends me a 30-page paper, I'm like, okay, that's gonna be three, four hours of my
life I won't get back.
00:23:32.309 --> 00:23:37.029
And it's sort of, I would much rather have it in a in a in a short format.
00:23:37.269 --> 00:23:45.029
So it's sort of like an even on X, when someone does a tutorial that's like 20 tweets long, I don't really think that's they, I think they're missing the point.
00:23:45.190 --> 00:23:51.910
There was a brilliant one by uh Ashish, one of our foundation circle, is a leading bladder cancer, and he did it in three tweets.
00:23:51.990 --> 00:23:56.150
And I just said, oncologist, take note, because that's what I want us to have.
00:23:56.390 --> 00:23:59.430
To come back to your question, and sorry I didn't answer about community.
00:23:59.509 --> 00:24:02.069
I think ultimately we won't be there quite yet.
00:24:02.230 --> 00:24:07.509
To start off with, we'll have content that is more sort of where the interaction is from the user with the website.
00:24:07.589 --> 00:24:14.150
But ultimately, we really want people's comments, want people to say that I'm using and her to find out how do you find the interstitial lung disease?
00:24:14.309 --> 00:24:15.750
What's the what's the nuance?
00:24:15.990 --> 00:24:25.349
So I think when I'm taking what's in people's brains, I'm very lucky when I you know I trained a dip to my training at Dana Far, but some of the best GU people in the world were there and are still there.
00:24:25.430 --> 00:24:31.990
And I could phone up someone like Tony Schwery, who's the head of the unit, there, and say, Tony, I'm about to use Nirvolamab for the first time.
00:24:32.069 --> 00:24:33.269
What should I be looking out for?
00:24:33.349 --> 00:24:38.630
And Tony said, bring them back in two weeks' time, make sure you check their thyroid function, warn them about diarrhea, etc.
00:24:39.029 --> 00:24:41.349
And you can't necessarily get that from the paper.
00:24:41.509 --> 00:24:45.750
Reading a paper that's just got grading on there, it it sort of works, doesn't work.
00:24:45.829 --> 00:24:49.269
And I think sometimes some of the grade one, two toxicities are underplayed.
00:24:49.430 --> 00:24:57.990
So I think having someone who's got real wealth of experience take you through it, and ultimately we will embed diagrams, videos, etc., within the algorithms.
00:24:58.069 --> 00:25:03.430
So I think I think it's the equivalent of being able to phone up the best people in the world and get them to take you through it.
00:25:03.829 --> 00:25:07.029
Yeah, and I think that is expertise and it's communication.
00:25:07.190 --> 00:25:14.630
I sometimes think of like I think a famous example of this is Steve Jobs on stage introducing the iPhone where it's like, it's your music on your phone.
00:25:14.789 --> 00:25:16.309
It's your music on your phone.
00:25:16.390 --> 00:25:17.349
He says it three or four times.
00:25:17.430 --> 00:25:18.390
He's like, Are you getting it?
00:25:18.470 --> 00:25:19.829
It's your music on your phone, right?
00:25:19.910 --> 00:25:23.349
Like
this is one of the most successful product launches ever.
00:25:23.589 --> 00:25:25.750
And he boils it down to one sentence.
00:25:25.990 --> 00:25:34.549
So this is uh this is my segue because he's also the person that I think of when I think of some of the potential impacts of misinformation.
00:25:34.710 --> 00:25:39.829
And because this is something that we talked about going in, was one of the goals of this is to combat misinformation.
00:25:39.910 --> 00:25:45.109
And I think it's a an a very interesting example because I'm sure you know much more about this than I do.
00:25:45.190 --> 00:25:54.069
But my understanding of it is that he essentially had a treatable cancer that he was attempting to treat with like organic fruit juices, basically.
00:25:54.309 --> 00:25:58.309
And by the time he was ready for real treatment, uh it was too late and he died.
00:25:58.470 --> 00:26:00.470
And it has nothing to do with intelligence, right?
00:26:00.549 --> 00:26:06.470
Nobody would argue he's not a smart, brilliant guy and and well or connections or access or anything else.
00:26:06.710 --> 00:26:14.230
So tell me a bit about what you're seeing out there for in or misinformation and what you think that doctors' responsibilities are in this space.
00:26:14.630 --> 00:26:15.990
I think that's a really good example.
00:26:16.069 --> 00:26:19.750
I don't know the details of his case too much, but that's my understanding of it.
00:26:19.910 --> 00:26:24.549
I think what we're seeing more and more of, and I think doctors have to look at themselves a bit here.
00:26:24.710 --> 00:26:34.470
It's very easy for us to criticize patients and say, oh, these people, they don't under, they don't get there's a reason they're not trusting doctors so much, and there's a reason they're looking for alternative sources.
00:26:34.630 --> 00:26:41.190
And some of, as you said, is some of the alternative sources are excellent communicators and also listeners, not my strongest point.
00:26:41.430 --> 00:26:47.349
So I think what we're hoping to do with open medicine is is listen, but also provide a trusted source.
00:26:47.509 --> 00:26:48.309
So it's interesting.
00:26:48.390 --> 00:26:49.670
I like generative AI.
00:26:49.750 --> 00:26:52.630
I think Chat GPT, etc., is actually a very good resource.
00:26:52.710 --> 00:27:01.670
But it's interesting, my friend's son that there's a meningitis outbreak in the UK where there was a couple of months ago, and lots of young kids were dying, which is very sad.
00:27:01.829 --> 00:27:10.470
And my friend, his son, who's in the sort of target age group, the kissing age group, 17-year-old boy, and he's in the area where there was the highest, the highest instance.
00:27:10.870 --> 00:27:11.349
What do you think?
00:27:11.430 --> 00:27:17.589
And I started looking on ChatGPT, and I thought I'm gonna phone someone up because I thought I'm not gonna take any chances with my godson Tom.
00:27:17.750 --> 00:27:26.870
So I think what we
want to have is the best source of resource, but something so what that showed me is that I like generative I, but I was gonna trust my friend's son on with it.
00:27:27.029 --> 00:27:30.950
So we want to have something that's trustworthy, where you can get that voice.
00:27:31.109 --> 00:27:39.750
So our content is going to be high quality, but also both in terms of the spec, but also in terms of the actual knowledge on there.
00:27:39.910 --> 00:27:43.349
So I think that's the bit where we want to have a trusted resource.
00:27:43.509 --> 00:27:49.109
At the moment, our target audience is doctors, but by the end of the year, we hope to have patient-related resources.
00:27:49.269 --> 00:27:51.990
And I think there's going to be more empowerment of patients.
00:27:52.150 --> 00:27:58.150
I've always been someone that's never, never, never minded patients coming in with information and things like that.
00:27:58.309 --> 00:28:00.789
It's very hard when you've got a cancer, it's very scary.
00:28:00.950 --> 00:28:03.029
And there's a lot of very smart patients out there.
00:28:03.190 --> 00:28:05.750
I learn from my patients every day, if not every week.
00:28:05.990 --> 00:28:09.190
It's a question of harnessing what's out there.
00:28:09.349 --> 00:28:13.670
I'm very happy when patients come and they're educated and they've they've educated themselves.
00:28:13.910 --> 00:28:19.829
It's concerning what that there are a lot of people out there trying to make money from patients, and that I think is awful.
00:28:19.910 --> 00:28:21.829
And there's a lot of poor information out there.
00:28:21.910 --> 00:28:24.230
So I hope what we will be is a filter for good information.
00:28:24.309 --> 00:28:24.390
Right.
00:28:24.710 --> 00:28:47.109
It's almost, you know, I think of it as you're in the States, you know, you could get your information from Instagram, you could get it from TikTok, you could get it from the Mayo Clinic, you can go and uh you could do a PubMed search, which I which is what I I'm not I'm not smart enough to read the actual papers, but I'll often look for a meta-analysis because that's kind of a nice, just give me the summary of all of the research.
00:28:47.269 --> 00:28:58.069
And I feel like creating that level of understanding, of recognizing what is a good and trusted source and and what might not be.
00:28:58.230 --> 00:29:02.710
I feel like that is a real challenge and opportunity for for you all.
00:29:02.870 --> 00:29:13.430
So, how how are you looking to build that brand of open medicine as, hey, these are not people trying to sell you a supplement or or whatever alternative cure.
00:29:13.509 --> 00:29:15.670
This is truly a trusted source of information.
00:29:15.990 --> 00:29:16.870
That's a really good point.
00:29:16.950 --> 00:29:19.670
Let me just go back to something you said there, because you said you're not smart enough.
00:29:19.829 --> 00:29:21.109
You're plenty smart enough.
00:29:21.269 --> 00:29:31.269
And
I think this is this is the way that academic academics, not just medicine, academic English graduates, we make it, we pitch it so we make you feel that you're not smart enough.
00:29:31.430 --> 00:29:37.190
The smart people would explain it in a way that made it explainable to our patients and to our trainees and to our colleagues.
00:29:37.269 --> 00:29:41.990
Because Einstein who said, if you really understand something, you can explain it simply.
00:29:42.150 --> 00:29:44.390
So it's not about you not being smart enough, Jonathan.
00:29:44.470 --> 00:29:48.230
It's about us creating a structure that is exclusive, not inclusive.
00:29:48.390 --> 00:29:50.630
So we want to do something that's really inclusive.
00:29:50.870 --> 00:29:56.470
To come back to what you were saying about a trusted source, I feel really, really very fortunate being the chief medical officer.
00:29:56.549 --> 00:29:57.910
I'd be able to go out and pick the team.
00:29:58.069 --> 00:30:04.950
So I've gone out, there's people that I know, I've got a big network, but there's also people I've thought, that person's brilliant at explaining stuff.
00:30:05.109 --> 00:30:11.670
So we've gone to some of the usual suspects, as it were, but we're really actually trying to get people, trainees, people in the community.
00:30:11.829 --> 00:30:16.710
I think community oncologists have been really talked about badly by a lot of buzz in academia.
00:30:16.870 --> 00:30:18.309
And I think these are good people.
00:30:18.470 --> 00:30:23.029
They're seeing the bulk of the patients, they're doing it under often less than ideal circumstances.
00:30:23.269 --> 00:30:30.789
We need to really make an effort to make sure that what we're the content we're providing, the way we're working, matches what they need.
00:30:30.950 --> 00:30:34.309
Not what we think they need, or not what we need, but the other way around.
00:30:34.390 --> 00:30:37.109
So exactly what you're saying on PubMed, I'm not X and Y.
00:30:37.190 --> 00:30:38.710
Well, it's PubMed's fault, it's not yours.
00:30:38.789 --> 00:30:39.990
And PubMed needs to change.
00:30:40.069 --> 00:30:42.150
Well, it is changing, isn't it, with most funding things.
00:30:42.230 --> 00:30:48.549
But so I think for us, it's about providing something that Jonathan can go to in six months' time and say, this is actually really good.
00:30:48.630 --> 00:30:53.589
And if you've got a friend who's going through something difficult, you can you feel comfortable signposting that way.
00:30:53.670 --> 00:30:58.150
So we're fortunate, we've got a foundation circle of some of the best people from around the world.
00:30:58.309 --> 00:31:02.309
Probably I think we almost hit 50 in oncology, and now we're going to metabolic medicine.
00:31:02.470 --> 00:31:14.870
So I think it's around that, but but I think we must never in our side make people feel that they're not smart enough or make them feel that they're that we're not providing stuff they can engage with.
00:31:15.109 --> 00:31:22.950
In my old hospital, we used to hand out 30-page written summaries of, say, dose of taxal and chemotherapy, prostate cancer.
00:31:23.190 --> 00:31:26.069
Almost half the people coming had a reading age less than 10.
00:31:26.150 --> 00:31:27.269
A lot of people couldn't read.
00:31:27.430 --> 00:31:31.589
That's not because they're stupid, it's just because they'd had less advantage than people and myself.
00:31:31.750 --> 00:31:34.710
But we carried on handing out the written information, the written information.
00:31:34.870 --> 00:31:36.150
We need to change that mentality.
00:31:36.710 --> 00:31:39.829
I have a story along these lines that I think is kind of interesting, right?
00:31:39.910 --> 00:31:49.910
Where you had brought up the generative AI earlier, but I had previously worked at a company that was doing a lot of work around some of the documentation that goes along with getting all these drugs to market.
00:31:49.990 --> 00:32:08.069
So one of the projects we were proposing was using generative AI essentially to take a clinical trial protocol and turn it into an ICF, an informed consent form, which is a requirement to document that's meant to be at basically a fifth grade, fourth, fifth grade reading level.
00:32:08.309 --> 00:32:12.230
So for those in the UK, what is that, like 10, 11-year-old person?
00:32:12.390 --> 00:32:18.789
And that's meant to help people truly understand what they're signing up for if they volunteer for a clinical trial or want to participate in one.
00:32:18.950 --> 00:32:27.029
And we were running into all types of pushback with the legal review team about doing this from the pharma company, it was big pharma.
00:32:27.430 --> 00:32:35.589
And what ended up getting that one pushed forward was they found out that the nurses at the trial sites themselves were saying, This is ridiculous.
00:32:35.750 --> 00:32:43.269
I'm gonna just take this thing and I'm gonna put it into Chat GPT and I'm gonna have it generate my own ICF, something my patients can actually understand.
00:32:43.509 --> 00:32:56.309
So I think that that then gets into a whole nother set of some ways like the cat's out of the bag or the horses left the barn or whatever animal analogy you want to use, but is getting control of this, right?
00:32:56.470 --> 00:33:06.950
And and focus on simplification, focus on communication is actually a huge opportunity for doctors, for pharma, for anybody who's looking to really further medical care.
00:33:07.430 --> 00:33:08.230
Yeah, no, absolutely.
00:33:08.309 --> 00:33:14.630
The the nurses get it, and and the patients go to the nurses because they're better communicators than the doctors, myself included.
00:33:14.789 --> 00:33:16.150
They're less intimidating.
00:33:16.309 --> 00:33:21.829
So we need to have something that is much more like that, less intimidating for everyone.
00:33:21.990 --> 00:33:31.029
You can make things my cousin I says, the head of genomics uh that Dana Farbuck, or the head of radiation bowlers, and genomic stability, he's a brilliant communicator because he strips it back.
00:33:31.190 --> 00:33:34.069
He takes it to a level for his audience, not for him.
00:33:34.230 --> 00:33:42.150
He can debate at a Nobel Prize level if he wants to, but actually he communicated, did a lot of work for refugee kids in in Syria, very, very proud of him.
00:33:42.309 --> 00:33:47.029
And you know, he was teaching 14-year-olds there who refugee kids, poor kids.
00:33:47.190 --> 00:33:50.789
And that takes a real talent to engage an audience like that.
00:33:50.950 --> 00:33:53.910
That's much harder than engage an audience at Harvard, in my opinion.
00:33:54.150 --> 00:33:54.309
Absolutely.
00:33:54.549 --> 00:33:55.349
Uh very good story.
00:33:55.430 --> 00:33:59.829
So, all right, so let's end with a bit of a forward-looking question.
00:34:00.309 --> 00:34:05.990
So if this vision succeeds, what changes for the average patient?
00:34:06.150 --> 00:34:11.269
And what would you think the real world impact would look like a few years from now?
00:34:11.750 --> 00:34:15.190
I think ultimately it's all about better improving patient care.
00:34:15.349 --> 00:34:28.789
So in cancer care, patients living longer and living better, so less side effects of treatment, better use of drugs, right dosing, so people get the right drug at the right time, at the right dose with the right supportive care.
00:34:29.029 --> 00:34:31.029
And it might be they don't need to have a therapy.
00:34:31.189 --> 00:34:33.189
We over-treat a lot in prostate cancer.
00:34:33.349 --> 00:34:36.949
So it might be someone with localized prostate cancer goes on to active surveillance.
00:34:37.109 --> 00:34:38.789
That would be a that would be a great win.
00:34:38.869 --> 00:34:53.269
They don't unnecessarily have a treatment, be it a drug treatment like I give that is the lowest testosterone or a surgical treatment that may cause incontinence or impotence or radiotherapy, which can cause bowel and bladder problems and potency problems.
00:34:53.509 --> 00:35:01.909
So I think ultimately, if open medicine works as we hope it will, it will be better patient care and improved quality and quantity of life for many, many patients.
00:35:02.069 --> 00:35:02.709
Global let.
00:35:03.029 --> 00:35:04.149
All right, Simon, we'll leave it there.
00:35:04.229 --> 00:35:05.029
Hopefully, we'll next time.
00:35:12.789 --> 00:35:17.669
And that's a wrap on today's episode of Pharma Sessions with me, Jonathan Kaske.
00:35:17.829 --> 00:35:25.829
If you enjoyed today's conversation, don't forget to hit follow or subscribe and share it with someone else in the pharma world who might need to hear it.
00:35:26.069 --> 00:35:33.909
For more on pharma trends, career growth, and business strategies, connect with me, Jonathan Kaske, on LinkedIn.
00:35:34.229 --> 00:35:36.389
Until next time, thanks for listening.